Seborrhoeic Dermatitis of the Scalp

Overview

Journal BMJ Clin Evid

Specialty General Medicine

Date 2015 May 29

PMID 26016669

Citations 10

Authors

Luigi Naldi

Janouk Diphoorn

Affiliations

Soon will be listed here.

Abstract

Introduction: Seborrhoeic dermatitis affects a variable proportion of the general population, ranging from 3% to 10%. Malassezia yeast species (previously referred to as Pityrosporum) are thought to be the responsible organisms, and cause inflammation by still poorly defined mechanisms. Seborrhoeic dermatitis tends to relapse after treatment.

Methods And Outcomes: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of topical treatments for seborrhoeic dermatitis of the scalp in adults? We searched: Medline, Embase, The Cochrane Library, and other important databases up to November 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 14 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifonazole, ciclopirox, ketoconazole, pyrithione zinc, selenium sulfide, tar shampoo, terbinafine, and topical corticosteroids (betamethasone valerate, clobetasol propionate, clobetasone butyrate, hydrocortisone, mometasone furoate).

Citing Articles

The Therapeutic Potential of Essential Oils in Managing Inflammatory Skin Conditions: A Scoping Review.

Dontje A, Schuiling-Veninga C, van Hunsel F, Ekhart C, Demirci F, Woerdenbag H Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794141 PMC: 11123799. DOI: 10.3390/ph17050571.

A Practical Algorithm for the Management of Superficial Folliculitis of the Scalp: 10 Years of Clinical and Dermoscopy Experience.

Starace M, Yamagata J, Cortez de Almeida R, Frattini S, Bruni F, Alessandrini A Dermatol Pract Concept. 2023; 13(3).

PMID: 37557142 PMC: 10412046. DOI: 10.5826/dpc.1303a131.

Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis?.

Spiewak R Int J Mol Sci. 2023; 24(13).

PMID: 37445645 PMC: 10342122. DOI: 10.3390/ijms241310468.

The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis.

Chen W, Xu J, Wu Y, Liang B, Yan M, Sun C Int J Biol Sci. 2023; 19(9):2879-2896.

PMID: 37324939 PMC: 10266072. DOI: 10.7150/ijbs.84994.

Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis.

Mahadi A, Rafi M, Shahriar T, Seemanta S, Rabbani M, Akter M Front Med (Lausanne). 2022; 9:876561.

PMID: 35647001 PMC: 9133810. DOI: 10.3389/fmed.2022.876561.

References

Elewski B, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta A . A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007; 6(10):1001-8. View

Ratnavel R, Squire R, Boorman G . Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007; 18(2):88-96. DOI: 10.1080/16537150601092944. View

Aly R, Katz H, Kempers S, Lookingbill D, Lowe N, Menter A . Ciclopirox gel for seborrheic dermatitis of the scalp. Int J Dermatol. 2003; 42 Suppl 1:19-22. DOI: 10.1046/j.1365-4362.42.s1.5.x. View

Tager A, Berlin C, SCHEN R . SEBORRHOEIC DERMATITIS IN ACUTE CARDIAC DISEASE. Br J Dermatol. 1964; 76:367-9. DOI: 10.1111/j.1365-2133.1964.tb14544.x. View

Carr M, PRYCE D, IVE F . Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol. 1987; 116(2):213-6. DOI: 10.1111/j.1365-2133.1987.tb05814.x. View

Naldi L, Rebora A . Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009; 360(4):387-96. DOI: 10.1056/NEJMcp0806464. View

JOHNSON M, Roberts J . Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat 11. 1978; (212):i-v, 1-72. View

Lebwohl M, Plott T . Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004; 43 Suppl 1:17-20. DOI: 10.1111/j.1461-1244.2004.02409.x. View

Reygagne P, Poncet M, Sidou F, Soto P . Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis. 2007; 79(5):397-403. View

10.

GOLDMAN W . Carcinogenicity of coal-tar shampoo. Lancet. 1995; 345(8945):326. DOI: 10.1016/s0140-6736(95)90317-8. View

11.

Schooten F, Moonen E, Rhijnsburger E, Van Agen B, Thijssen H, Kleinjans J . Dermal uptake of polycyclic aromatic hydrocarbons after hairwash with coal-tar shampoo. Lancet. 1994; 344(8935):1505-6. DOI: 10.1016/s0140-6736(94)90323-9. View

12.

Coopman S, Johnson R, Platt R, Stern R . Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993; 328(23):1670-4. DOI: 10.1056/NEJM199306103282304. View

13.

Schooten F . Carcinogenic consequences of coal-tar shampoo?. Lancet. 1995; 345(8965):1635. DOI: 10.1016/s0140-6736(95)90140-x. View

14.

Segal R, David M, Ingber A, Lurie R, SANDBANK M . Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol. 1992; 72(6):454-5. DOI: 102340/0001555572454455. View

15.

Altmeyer P, Hoffmann K . Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. Int J Dermatol. 2004; 43 Suppl 1:9-12. DOI: 10.1111/j.1461-1244.2004.02381.x. View

16.

Danby F, Maddin W, Margesson L, Rosenthal D . A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993; 29(6):1008-12. DOI: 10.1016/0190-9622(93)70282-x. View

17.

Shuster S, Meynadier J, Kerl H, Nolting S . Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. Arch Dermatol. 2005; 141(1):47-52. DOI: 10.1001/archderm.141.1.47. View

18.

Barba A, Piubello W, Vantini I, Caliari S, Cocchetto R, Vallaperta P . Skin lesions in chronic alcoholic pancreatitis. Dermatologica. 1982; 164(5):322-6. DOI: 10.1159/000250109. View

19.

Bettley F, MARTEN R . Unilateral seborrheic dermatitis following a nerve lesion. AMA Arch Derm. 1956; 73(2):110-5. DOI: 10.1001/archderm.1956.01550020010002. View

20.

Bailey P, Arrowsmith C, Darling K, Dexter J, Eklund J, Lane A . A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity. Int J Cosmet Sci. 2008; 25(4):183-8. DOI: 10.1046/j.1467-2494.2003.00183.x. View